Corona Vaccine: Leopoldina expert calls for faster deployment – “several very good candidates”

Update May 14, 9:25 p.m.: Around the world after one vaccine against that coronavirus wanted. Just with that vaccine A return to conditions as before the pandemic is said to be possible. But the way until such a product can be administered in bulk is too much, too much, says a senior expert. Prof. Andreas Wheel break, Corona expert and immunologist from the Academy of Sciences LeopoldinAccording to Chancellor Merkel’s advice she bases her decisions, the image (article behind the payment barrier) now reads:There are several very good candidates for an effective SARS-CoV-2 vaccine., and I suppose several will work very well. ”

According to the report, Radbruch recommends that these agents be tested faster in humans. “It currently takes so longbecause, as prescribed for each medicine, there must be many phases of testing. ” At least for vaccines that are similar to established vaccines, there should be a shortcut, he says.

Radbruch does not see an increased risk from the first tests. Look at the self-experiment of the pharmaceutical entrepreneur Winfried Stöcker. The latter had a substance made in his laboratory and administered it. After that, he says he is immune.

Radbruch would also inject this substance, says the immunologist: “For years we have known the principle of vaccination with so-called recombinant antigens. Hepatitis B, influenza vaccines and others work in the same way. I think the risk of such a vaccine not working is very low. “

Coronavirus: Tübingen company CureVac reports vaccine success – Sanofi drug rampage

Update May 14, 4:58 p.m.: Member of EU– Parliaments have advocated access to coronavirus–vaccine if necessary about so-called Compulsory licenses to to guarantee. Legally, it is possible, medicines and vaccines too without the express approval of the original manufacturer Manufacturing in the EU, PPE Group spokesperson for health policy Peter Liese (CDU) emphasized in a plenary debate on Thursday. If a vaccine is first developed in the United States or China, the EU must do everything possible to ensure that the vaccine is actually available to all countries.

With compulsory licenses, European companies are likely to produce the vaccine without the approval of the patent holder. This would be offset by a state-determined fee.

However, the WHO has a devastating crown forecast: “It is very difficult to predict …”

Coronavirus: Tübingen company CureVac reports vaccine success

Update May 14, 8:08 p.m.: the The Tübingen biotech company CureVac It released the first data on its coronavirus vaccine project on Thursday afternoon. Consequently, the Positive preclinical results of low-dose vaccine accomplished. The company said, according to a report by n-tv With that, the available data showed a “balanced immune response combined with the formation of a high number of virus neutralizing titers (VNT) and T cells.” VNTs are a key indicator of whether the potential vaccine can cause a strong immune response, which can then neutralize the corona pathogen. First clinic Studies with healthy volunteers. want CureVac now in June Start.

Meanwhile stressed out France Thursday in controversy over a possible preference of the United States for that Corona vaccine of the French Pharmaceutical giant Sanofi should be available to everyone. Élyséek’s circles said that comments by Sanofi Director General Paul Hudson on the priority of the United States would in no way be consistent with continued cooperation between Sanofi and the French government.

Coronavirus vaccine: Macron wants to make a vaccine available to everyone

French President Emmanuel Macron concentrate your efforts on a coordinated and multilateral responseSo that a possible vaccine is available to everyone, there are no limits. There should be a meeting with Sanofi next week.

Update May 14, 2:31 p.m.: Now that too EU Commission about the pharmaceutical company announcement Sanofi, a possible First deliver the coronavirus vaccine to the United Statesexpressed The European authority announced on Thursday Distribution to all countries is required. “The Covid-19 vaccine should be a global public good,” a spokesman said Thursday. “Access to it must be fair and universal.”

First report of May 14, 2020:

Paris – The French Pharmaceutical Giant Sanofi has announced a future Coronavirus vaccine to offer everyone. Olivier Bogillot, the group’s French chief, emphasized Thursday on the television station. BFMTV: It is clear that the vaccine will be accessible to everyone. Statements by the General Manager of Sanofi Paul hudson It had previously sounded a little different and caused a sensation.

The coronavirus vaccine is said to go to the United States first, according to Sanofi’s CEO.

As reported by the American financial news agency Bloomberg on its website on Wednesday, Hudson had made it clear in an interview that the Priority of the United States in the vaccine would have. The United States would have been the first to support the investigation. The agency also quoted Britain’s Hudson as saying the United States government “did that. Right to the largest advance order“. Sanofi” first “will supply the United States because they” share the risk “in the investigation. * According to Hudson, the advantage could apply for several days or weeks.

Bogillot confirmed Thursday But not nowthat the United States could get delivery priority after the vaccine was developed. It is true that the pharmaceutical company has begun working with the United States government, Bogillot admitted, according to information from the German Press Agency. He also emphasized that the The EU must also help “effectively”to make the vaccine available. Bogillot further said, according to the AFP news agency, that the company would not give the United States * a priority vaccine if the EU were “so objective” in financing its development.

Coronavirus: Sanofi has been working on the vaccine since April, and wants to accelerate development

However, Hudson’s statements made in France review In the pharmaceutical company. It would be unacceptable if a country had privileged access to a vaccine, he said. Agnès Pannier-Runacher, State Secretary at the French Ministry of Economy and Finance., on the radio station Southern radio. Meanwhile, Hudson has apparently also paddled. One of the recent Sanofi Group Twitter posts is once again focusing its statement on making the vaccine accessible to all, regardless of nationality.

Sanofi has been working with the British pharmaceutical company to find a vaccine since April GlaxoSmithKline together. But the tests have not yet started and one successful media against the virus is probably available at the end of next year at the earliest to be. Sanofi now said via Twitter that the company’s teams are trying to accelerate the development of a vaccine. Your project will be part of United States Agency for Biomedical Research and Development (Barda) supported. Report to the United States Department of Health.

Coronavirus vaccine: testimony of Sanofi director caused outrage in France

Sanofi announced Wednesday night that “production on American soil is primarily destined for the United States” and “the rest of the production capacity will go to Europe, France and the rest of the world.” However, the company promised to possible vaccine “accessible to all” near. objective either the The United States, France and Europe * would receive the vaccine “at the same time”. In France, Hudson’s remarks caused outrage primarily because Sanofi had received tens of millions in research loans from the French state in recent years.

You can also read many previous news about the development of vaccines against coronavirus. Merkur.de*. For example, vaccine trials started in the UK in late April. You can find more information in the video below.

* Merkur.de is part of the national network of publishers Ippen-Digital.

cia with dpa and AFP

List of rubric lists: © dpa / Sebastian Gollnow